Match!
Kate Sully
Adelphi University
Life expectancyQualitative researchImmunologyFamily medicineMedicine
6Publications
1H-index
1Citations
What is this?
Publications 7
Newest
#1Rebecca CrawfordH-Index: 2
#2Kate Sully (Adelphi University)H-Index: 1
Last. Adam Gater (Adelphi University)H-Index: 8
view all 9 authors...
Expectations relating to treatment and survival, and factors influencing treatment decisions are not well understood in adult patients with acute myeloid leukemia. This study analyzed combined findings from a targeted literature review with patient-reported information shared on YouTube to further understand patient perspectives in hematologic cancers and, in particular, acute myeloid leukemia. The targeted literature review included articles concerning patient (aged ≥ 18 years) experiences or p...
Source
#1Thomas W. LeBlanc (Duke University)H-Index: 20
#2Roland B. Walter (Fred Hutchinson Cancer Research Center)H-Index: 40
Last. Dawn Maze (Princess Margaret Cancer Centre)H-Index: 4
view all 15 authors...
Source
#1Kate Sully (Adelphi University)H-Index: 1
#2Andrew Trigg (Adelphi University)H-Index: 2
Last. Kim Cocks (Adelphi University)H-Index: 5
view all 9 authors...
1 CitationsSource
#1Hannah Staunton (Hoffmann-La Roche)
#2Tom Willgoss (Hoffmann-La Roche)H-Index: 1
Last. Rob Arbuckle (Adelphi University)H-Index: 6
view all 7 authors...
Establishing meaningful change thresholds for Clinical Outcome Assessments (COA) is critical for score interpretation. While anchor- and distribution-based statistical methods are well-established, qualitative approaches are less frequently used. This commentary summarizes and expands on a symposium presented at the International Society for Quality of Life Research (ISOQOL) 2017 annual conference, which provided an overview of qualitative methods that can be used to support understanding of mea...
Source
#1Rob Arbuckle (Adelphi University)H-Index: 6
#2Hannah Staunton (Adelphi University)H-Index: 1
Last. Linda Nelsen (GSK: GlaxoSmithKline)H-Index: 13
view all 7 authors...
Abstract Introduction Diary-derived symptom score and rescue medication use endpoints, such as symptom-free days (SFDs) and rescue medication-free days (RFD), are frequently used as clinical trial endpoints. Estimates of meaningful change for SFDs and RFDs have not been generated in pediatric populations. This research aimed to generate evidence supporting estimates of the individual within-patient changes that constitute an important or meaningful change in SFDs, RFDs, and updated estimates on ...
1 CitationsSource
#1Emre Yucel (Newbury College)H-Index: 1
#2Andrew Trigg (Adelphi University)H-Index: 2
Last. Kim Cocks (Adelphi University)H-Index: 5
view all 8 authors...
Introduction In addition to efficacy and safety, novel regimens for the treatment of multiple myeloma (MM) should be assessed in terms of disease-related symptoms, the adverse events patient9s experience, and their effect on health-related quality of life (HRQOL). Patient-reported outcome (PRO) measures capture these experiences from the patient9s perspective. However, an interpretative challenge of PROs is understanding the magnitude of change that can be considered clinically meaningful. The E...
Source
#1Chloe Johnson (Adelphi University)H-Index: 1
#2Timothy J Bell (Pfizer)H-Index: 7
Last. Adam Gater (Adelphi University)H-Index: 8
view all 6 authors...
Source
1